HomeDRUG • NASDAQ
add
Bright Minds Biosciences Inc
Previous close
$1.10
Day range
$1.05 - $1.13
Year range
$1.05 - $6.44
Market cap
6.52M CAD
Avg Volume
20.49K
P/E ratio
-
Dividend yield
-
Primary exchange
CNSX
Market news
Financials
Income Statement
Revenue
Net income
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 1.62M | -28.07% |
Net income | -1.68M | 27.88% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 6.76M | -39.69% |
Total assets | 6.89M | -40.37% |
Total liabilities | 854.16K | 46.60% |
Total equity | 6.03M | — |
Shares outstanding | 4.46M | — |
Price to book | 0.81 | — |
Return on assets | -58.98% | — |
Return on capital | -63.63% | — |
Cash Flow
Net change in cash
(CAD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -1.68M | 27.88% |
Cash from operations | -822.09K | 69.14% |
Cash from investing | — | — |
Cash from financing | 878.04K | -61.05% |
Net change in cash | 13.66K | 103.28% |
Free cash flow | -199.78K | 88.60% |
About
Founded
2017
Website